nach oben

Rheumatology International

Erschienen in:

12.04.2021 | Observational Research

Contribution of Arab Countries to Familial Mediterranean Fever Research: a PubMed-based bibliometric analysis

verfasst von: Diala El Masri, Bachar Alsaayed, Jad El Masri, Bachir Zreika, Hani Chanbour, Pascale Salameh

Erschienen in: Rheumatology International | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disease. One of the feared complications of FMF, amyloidosis is often correlated with an increased mortality rate. The severity of the disease is linked with different mutations in the MEFV gene that may favor different outcomes (amyloidosis, Bechet’s disease…). Although several countries worldwide contribute remarkably to research related to FMF, Arab countries make up only a small part of this contribution. This study aims to estimate numerically the contribution of the Arab world to research conducted on FMF. PubMed is used to quantitate the number of FMF-related articles published by each Arab country from 2004 till 2019. The retrieved numbers are normalized with respect to each country’s average population and average Gross Domestic Product (GDP) and are also compared to those of some non-Arab countries having high FMF prevalence. In comparison with some non-Arab countries, the Arab world has a minor contribution of 3.80% to the total FMF-related publications, faced by 24.93% solely by Turkey. Out of total research done by Arab countries, FMF-related articles constitute no more than 0.133%. When normalized against the average population, Tunisia ranks first, followed by Lebanon. Similarly, normalizing the retrieved numbers of articles against average GDP shows that Tunisia and Lebanon come first and second, respectively. Only 8 Arab countries published a total of 13 articles concerning amyloidosis which makes 4.7% of the total Arabic FMF published articles. This study reflects an undoubtable need for more research to be conducted on FMF by the Arab countries, which suffer greatly from immense shortage in research productivity, due to the many obstacles and limitations these countries face every day.

El-Shanti H, Majeed HA, El-Khateeb M (2006) Familial Mediterranean fever in Arabs. Lancet 367:1016–1024. https://doi.org/10.1016/S0140-6736(06)68430-4CrossRefPubMed

Ozdogan H, Ugurlu S (2019) Familial Mediterranean fever. Presse Med 48:e61–e76. https://doi.org/10.1016/j.lpm.2018.08.014CrossRefPubMed

Ben-Chetrit E, Touitou I (2009) Familial Mediterranean fever in the World. Arthritis Care Res 61:1447–1453. https://doi.org/10.1002/art.24458CrossRef

Yang J, Xu H, Shao F (2014) The immunological function of familial Mediterranean fever disease protein Pyrin. Sci China Life Sci 57:1156–1161. https://doi.org/10.1007/s11427-014-4758-3CrossRefPubMed

Park H, Bourla AB, Kastner DL et al (2012) Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol 12:570–580. https://doi.org/10.1038/nri3261CrossRefPubMedPubMedCentral

Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253. https://doi.org/10.1016/0002-9343(67)90167-2CrossRefPubMed

Benamer HT, Bakoush O (2009) Arab nations lagging behind other Middle Eastern countries in biomedical research: a comparative study. BMC Med Res Methodol 9:26. https://doi.org/10.1186/1471-2288-9-26CrossRefPubMedPubMedCentral

Almansour S (2016) The crisis of research and global recognition in Arab universities. Near Middle Eastern J Res Education 2016:1. https://doi.org/10.5339/nmejre.2016.1CrossRef

Rosselli D (1999) Geography of biomedical publications. Lancet 354:517. https://doi.org/10.1016/S0140-6736(05)75555-0CrossRefPubMed

10.

Kuemmerle-Deschner JB, Quartier P, Kone-Paut I et al (2020) Burden of illness in hereditary periodic fevers: a multinational observational patient diary study. Clin Exp Rheumatol 38(Suppl 127):26–34PubMed

11.

Hama I, Ilham R, Ouzeddoun N et al (2012) Renal amyloidosis due to familial mediterranean fever misdiagnosed. Indian J Hum Genet 18:363–365. https://doi.org/10.4103/0971-6866.108043CrossRefPubMedPubMedCentral

12.

La Regina M, Nucera G, Diaco M et al (2003) Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 11:50–56. https://doi.org/10.1038/sj.ejhg.5200916CrossRefPubMed

13.

Bhatt H, Cascella M (2020) Familial Mediterranean fever. In: StatPearls. StatPearls Publishing, Treasure Island, FL

14.

Manna R, Rigante D (2019) Familial Mediterranean fever: assessing the overall clinical impact and formulating treatment plans. Mediterr J Hematol Infect Dis 11:e2019027–e2019027. https://doi.org/10.4084/MJHID.2019.027CrossRefPubMedPubMedCentral

15.

Smith MD, Angove RC (1980) Familial Mediterranean fever in Australia. Med J Aust 1:77–78. https://doi.org/10.5694/j.1326-5377.1980.tb134632.xCrossRefPubMed

16.

GDP (current US$) | Data. https://data.worldbank.org/indicator/NY.GDP.MKTP.CD. Accessed 7 Jan 2021

17.

World Population Prospects—Population Division—United Nations. https://population.un.org/wpp/Download/Standard/Population/. Accessed 7 Jan 2021

18.

Salhab HA, Salameh P, Hajj H, Hosseini H (2018) Stroke in the Arab World: A bibliometric analysis of research activity (2002–2016). eNeurologicalSci 13:40–45. https://doi.org/10.1016/j.ensci.2018.11.010CrossRefPubMedPubMedCentral

19.

Daou L, El Hage S, Wakim E et al (2021) Psoriasis: a bibliometric analysis in the Arab World (2004–2019). Australas J Dermatol 62:e19–e23. https://doi.org/10.1111/ajd.13407CrossRefPubMed

20.

El Rassi R, Meho LI, Nahlawi A et al (2018) Medical research productivity in the Arab countries: 2007–2016 bibliometric analysis. J Glob Health 8:020411–020411. https://doi.org/10.7189/jogh.08.020411CrossRefPubMedPubMedCentral

21.

Belmahi L, Sefiani A, Fouveau C et al (2006) Prevalence and distribution of MEFV mutations among Arabs from the Maghreb patients suffering from familial Mediterranean fever. CR Biol 329:71–74. https://doi.org/10.1016/j.crvi.2005.11.005CrossRef

22.

Zeinoun P, Akl EA, Maalouf FT, Meho LI (2020) The Arab Region’s contribution to global mental health research (2009–2018): a bibliometric analysis. Front Psych 11:182. https://doi.org/10.3389/fpsyt.2020.00182CrossRef

23.

Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF (2014) Assessing urology and nephrology research activity in Arab countries using ISI web of science bibliometric database. BMC Res Notes 7:258. https://doi.org/10.1186/1756-0500-7-258CrossRefPubMedPubMedCentral

24.

Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R (2014) A bibliometric analysis of toxicology research productivity in Middle Eastern Arab countries during a 10-year period (2003–2012). Health Res Policy Syst 12:4. https://doi.org/10.1186/1478-4505-12-4CrossRefPubMedPubMedCentral

25.

Sweileh WM, Al-Jabi SW, Shanti YI et al (2015) Contribution of Arab researchers to ophthalmology: a bibliometric and comparative analysis. Springerplus. https://doi.org/10.1186/s40064-015-0806-0CrossRefPubMedPubMedCentral

26.

Khachfe HH, Refaat MM (2019) Bibliometric analysis of cardiovascular disease research activity in the Arab World. Int Cardiovasc Forum J 15 https://doi.org/10.17987/icfj.v15i0.554

27.

Mokdad AH, Jaber S, Aziz MIA et al (2014) The state of health in the Arab world, 1990–2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet 383:309–320. https://doi.org/10.1016/S0140-6736(13)62189-3CrossRefPubMed

28.

Masood E (2002) Blooms in the desert. Nature 416:120–122. https://doi.org/10.1038/416120aCrossRefPubMed

29.

Majeed HA, Rawashdeh M, el-Shanti H et al (1999) Familial Mediterranean fever in children: the expanded clinical profile. QJM 92:309–318. https://doi.org/10.1093/qjmed/92.6.309CrossRefPubMed

30.

Ben-Zvi I, Livneh A (2011) Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 7:105–112. https://doi.org/10.1038/nrrheum.2010.181CrossRefPubMed

31.

Jalkh N, Génin E, Chouery E et al (2008) Familial Mediterranean fever in Lebanon: founder effects for different MEFV mutations. Ann Hum Genet 72:41–47. https://doi.org/10.1111/j.1469-1809.2007.00386.xCrossRefPubMed

32.

Al-Alami J, Tayeh M, Najib D et al (2003) Familial Mediterranean Fever mutation frequencies and carrier rates among a mixed Arabic population. Saudi Med J 24:1055–1059PubMed

33.

Medlej-Hashim M, Serre J-L, Corbani S et al (2005) Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. Eur J Med Genet 48:412–420. https://doi.org/10.1016/j.ejmg.2005.05.010CrossRefPubMed

34.

Wilson M, Abou-Elalla AA, Zakaria MT et al (2016) Serum amyloid A type 1 gene polymorphism in Egyptian Children with familial Mediterranean fever. Pathobiology 83:295–300. https://doi.org/10.1159/000444933CrossRefPubMed

35.

Zerkaoui M, Laarabi FZ, Ajhoun Y et al (2018) A novel single variant in the MEFV gene causing Mediterranean fever and Behçet’s disease: a case report. J Med Case Rep 12:53. https://doi.org/10.1186/s13256-017-1552-4CrossRefPubMedPubMedCentral

36.

Dundar M, Kiraz A, Emirogullari EF et al (2012) A molecular analysis of familial Mediterranean fever disease in a cohort of Turkish patients. Ann Saudi Med 32:343–348. https://doi.org/10.5144/0256-4947.2012.343CrossRefPubMedPubMedCentral

37.

Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146:467–478. https://doi.org/10.1111/j.1365-2141.2009.07733.xCrossRefPubMedPubMedCentral

38.

Ait-Idir D, Djerdjouri B, Bouldjennet F et al (2017) The M694I/M694I genotype: a genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever. Eur J Med Genet 60:149–153. https://doi.org/10.1016/j.ejmg.2016.12.003CrossRefPubMed

39.

Medlej-Hashim M, Delague V, Chouery E et al (2004) Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet 5:4–4. https://doi.org/10.1186/1471-2350-5-4CrossRefPubMedPubMedCentral

Titel: Contribution of Arab Countries to Familial Mediterranean Fever Research: a PubMed-based bibliometric analysis
verfasst von: Diala El Masri
Bachar Alsaayed
Jad El Masri
Bachir Zreika
Hani Chanbour
Pascale Salameh
Publikationsdatum: 12.04.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 1/2022
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-021-04852-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Galectin-3: a new biomarker for differentiating periodic fever, adenitis, pharyngitis, aphthous stomatitis (PFAPA) syndrome from familial Mediterranean fever?

COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study

The relationship between defects in DNA repair genes and autoinflammatory diseases

Sequence analysis in Familial Mediterranean Fever patients with no confirmatory genotype

Contribution of Arab countries to Behçet disease research: a PubMed-based bibliometric and altmetric analysis